De Novo Design of High-Affinity Antibody Variable Regions (scFv) Against the SARS-CoV-2 Spike Protein

doi 10.1101/2020.04.09.034868
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights

2020English

SARS-CoV-2 Prion-Like Domains in Spike Proteins Enables Higher Affinity to ACE2

2020English

The First-In-Class Peptide Binder to the SARS-CoV-2 Spike Protein

2020English

Selection, Affinity Maturation, and Characterization of a Human scFv Antibody Against CEA Protein

BMC Cancer
Cancer ResearchOncologyGenetics
2006English

SARS-CoV-2 Invades Host Cells via a Novel Route: CD147-spike Protein

2020English

Distinct Structural Flexibility Within SARS-CoV-2 Spike Protein Reveals Potential Therapeutic Targets

2020English

Monoclonal Antibodies for the S2 Subunit of Spike of SARS-CoV Cross-React With the Newly-Emerged SARS-CoV-2

2020English

AI-aided Design of Novel Targeted Covalent Inhibitors Against SARS-CoV-2

2020English

A Humanized Neutralizing Antibody Against MERS-CoV Targeting the Receptor-Binding Domain of the Spike Protein

Cell Research
Cell BiologyMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy